Echo Therapeutics

Echo Therapeutics is developing its non-invasive (transdermal & without needles), wireless, continuous glucose monitoring (CGM) system. A significant opportunity exists for the Company’s CGM to be used in the diabetes fitness, weight loss and personal lifestyle wearable-health space. Echo developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals.